- Accueil >
- Publications >
- Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance
Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance
Auteurs
Elodie Pramil, Linda Herbi Bastian, Thomas Denèfle, Fariba Nemati, Malina Xiao, Eva Lardé, Karim Maloum, Damien Roos-Weil, Elise Chapiro, Magali Le Garff-Tavernier, Frédéric Davi, Didier Decaudin, Marika Sarfati, Florence Nguyen-Khac, Hélène Merle-Béral, Philippe Karoyan, Santos A. Susin
Résumé
Key Points
N-methylated thrombospondin-1 mimetic peptides selectively kill the leukemic CD5+ B cells, sparing mature and precursor nontumor cells. CD47 peptide triggering eliminates drug-resistant CLL cells by inducing an original form of cell death regulated by G proteins.
